1. Home
  2. UXIN vs EBS Comparison

UXIN vs EBS Comparison

Compare UXIN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uxin Limited ADS

UXIN

Uxin Limited ADS

HOLD

Current Price

$1.39

Market Cap

495.0M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$7.36

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UXIN
EBS
Founded
2011
1998
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
495.0M
413.3M
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
UXIN
EBS
Price
$1.39
$7.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
233.5K
656.7K
Earning Date
04-10-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.83
EPS
N/A
0.07
Revenue
N/A
$742,900,000.00
Revenue This Year
$245.77
$1.29
Revenue Next Year
$44.72
N/A
P/E Ratio
$4.05
$103.14
Revenue Growth
N/A
N/A
52 Week Low
$1.25
$5.87
52 Week High
$4.50
$14.06

Technical Indicators

Market Signals
Indicator
UXIN
EBS
Relative Strength Index (RSI) 36.07 39.76
Support Level N/A N/A
Resistance Level $3.15 $8.59
Average True Range (ATR) 0.12 0.24
MACD -0.00 -0.02
Stochastic Oscillator 26.16 31.03

Price Performance

Historical Comparison
UXIN
EBS

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates a car retailer, pioneering industry transformation with production, new retail experiences, and digital empowerment in China. With its inventory-owning model, it provides customers a comprehensive transaction solution that encompasses the entire value chain, ranging from used-car acquisition, inspection, and reconditioning, warehousing, as well as pre-sales and after-sales services. The group offers high-quality and value-for-money used cars as well as superior full suites of services to customers through a reliable, one-stop, and hassle-free transaction experience. It derives revenues from retail vehicle sales, wholesale vehicle sales, and other businesses. The Group generates its revenues in China.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: